Aarti Pharmalabs Limited (NSE:AARTIPHARM)
642.35
+9.10 (1.44%)
Jun 1, 2026, 3:29 PM IST
Aarti Pharmalabs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 96.16 | 67.34 | 236.35 | 121.21 | 832.73 |
Short-Term Investments | - | 491.23 | 706.82 | - | - |
Trading Asset Securities | - | - | - | 509.9 | - |
Cash & Short-Term Investments | 96.16 | 558.57 | 943.17 | 631.11 | 832.73 |
Cash Growth | -82.78% | -40.78% | 49.45% | -24.21% | 33209.36% |
Accounts Receivable | 5,833 | 5,754 | 5,193 | 4,501 | 3,767 |
Other Receivables | 99.35 | 93.57 | 108.61 | 53.71 | 65.42 |
Receivables | 5,938 | 5,858 | 5,315 | 4,567 | 3,893 |
Inventory | 6,403 | 5,876 | 6,429 | 6,020 | 4,755 |
Prepaid Expenses | - | 63.44 | 61.48 | 23.25 | 41.96 |
Other Current Assets | 1,536 | 866.12 | 708.61 | 388.04 | 758.89 |
Total Current Assets | 13,973 | 13,222 | 13,456 | 11,630 | 10,281 |
Property, Plant & Equipment | 17,067 | 14,107 | 10,932 | 9,861 | 9,453 |
Long-Term Investments | 1,938 | 292.41 | 367.8 | 355.25 | 322.26 |
Goodwill | - | 17.81 | 17.81 | 17.81 | 17.81 |
Other Intangible Assets | 1,239 | 984.4 | 752.74 | 398.5 | 223.65 |
Other Long-Term Assets | 522.4 | 367.74 | 235.89 | 119.32 | 100.67 |
Total Assets | 34,817 | 29,064 | 25,821 | 22,440 | 20,399 |
Accounts Payable | 3,345 | 2,778 | 3,783 | 3,395 | 2,146 |
Accrued Expenses | - | 509.18 | 373.34 | 198.41 | 87.83 |
Short-Term Debt | 4,998 | 2,928 | 2,641 | 2,142 | 3,377 |
Current Portion of Long-Term Debt | - | - | - | - | 3.42 |
Current Portion of Leases | 165.51 | 50.94 | 44.91 | 4.45 | 12.44 |
Current Income Taxes Payable | - | 11.45 | - | 35.15 | 75 |
Other Current Liabilities | 866.57 | 292.66 | 101.83 | 231.68 | 104.8 |
Total Current Liabilities | 9,376 | 6,570 | 6,944 | 6,006 | 5,807 |
Long-Term Debt | 1,858 | 1,113 | 0.39 | 1.84 | 5.55 |
Long-Term Leases | 521.76 | 116.69 | 166.59 | 5.32 | 15.32 |
Pension & Post-Retirement Benefits | - | 8.31 | 6.18 | 5.47 | - |
Long-Term Deferred Tax Liabilities | 1,343 | 1,284 | 1,079 | 788.38 | 706.7 |
Other Long-Term Liabilities | 472.12 | 72.87 | 54.41 | 48.14 | - |
Total Liabilities | 13,571 | 9,165 | 8,251 | 6,855 | 6,534 |
Common Stock | 453.29 | 453.17 | 453.13 | 453.13 | 2.5 |
Additional Paid-In Capital | - | 4,408 | 4,403 | 4,403 | 4,403 |
Retained Earnings | - | 14,131 | 11,734 | 9,746 | 8,006 |
Comprehensive Income & Other | 20,793 | 906.85 | 979.81 | 982.06 | 1,453 |
Shareholders' Equity | 21,246 | 19,899 | 17,570 | 15,585 | 13,865 |
Total Liabilities & Equity | 34,817 | 29,064 | 25,821 | 22,440 | 20,399 |
Total Debt | 7,544 | 4,208 | 2,853 | 2,153 | 3,414 |
Net Cash (Debt) | -7,447 | -3,650 | -1,909 | -1,522 | -2,581 |
Net Cash Per Share | -82.06 | -40.24 | -21.07 | -16.79 | -28.48 |
Filing Date Shares Outstanding | 90.69 | 90.63 | 90.63 | 90.63 | 90.63 |
Total Common Shares Outstanding | 90.69 | 90.63 | 90.63 | 90.63 | 90.63 |
Working Capital | 4,597 | 6,651 | 6,513 | 5,624 | 4,475 |
Book Value Per Share | 234.27 | 219.55 | 193.88 | 171.97 | 152.99 |
Tangible Book Value | 20,007 | 18,897 | 16,800 | 15,169 | 13,623 |
Tangible Book Value Per Share | 220.61 | 208.49 | 185.38 | 167.38 | 150.32 |
Land | - | 841.46 | 779.38 | 669.32 | 641.01 |
Buildings | - | 1,848 | 1,668 | 1,568 | 1,202 |
Machinery | - | 14,218 | 12,789 | 11,610 | 9,941 |
Construction In Progress | - | 3,066 | 784.97 | 622.04 | 1,652 |